| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 590.26B | 522.10B | 442.84B | 483.66B | 489.87B |
| Gross Profit | 93.65B | 94.47B | 77.23B | 85.45B | 85.93B |
| EBITDA | 29.38B | 35.66B | 19.76B | 25.84B | 34.08B |
| Net Income | 1.03B | 133.23M | -3.87B | 1.17B | 5.75B |
Balance Sheet | |||||
| Total Assets | 774.86B | 695.97B | 665.73B | 681.07B | 680.69B |
| Cash, Cash Equivalents and Short-Term Investments | 100.11B | 87.59B | 91.09B | 112.05B | 115.51B |
| Total Debt | 200.50B | 155.17B | 157.50B | 161.76B | 166.53B |
| Total Liabilities | 666.90B | 598.32B | 565.61B | 578.92B | 587.88B |
| Stockholders Equity | 55.82B | 55.74B | 58.33B | 63.95B | 62.83B |
Cash Flow | |||||
| Free Cash Flow | -17.34B | 14.30B | -5.82B | 33.26B | 12.31B |
| Operating Cash Flow | -642.49M | 27.08B | 8.96B | 47.55B | 22.17B |
| Investing Cash Flow | -19.06B | -9.94B | -10.36B | -14.85B | -4.88B |
| Financing Cash Flow | 29.11B | -14.13B | -22.63B | -15.04B | -24.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$150.34B | 6.70 | 23.18% | 4.17% | 18.95% | -4.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | HK$3.42B | -3.67 | -11.23% | ― | -4.90% | 6.88% | |
49 Neutral | HK$23.70B | 1.76 | 1.82% | ― | 18.26% | 690.92% | |
48 Neutral | HK$5.27B | 95.52 | 1.82% | ― | 0.92% | ― | |
43 Neutral | HK$16.33B | -106.74 | -3.88% | ― | 18.05% | 60.93% |